SCHEMBL22988958

SCHEMBL22988958

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-n4c5ccc6cccc7oc8cccc9ccc4c(c98)c5c67)cc3)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.34
MEN1 O00255 5/20 0.33
KMT2A Q03164 5/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 3/20 0.33
MAPT P10636 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
HPGD P15428 2/20 0.33
PDE6D O43924 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
HSD17B10 Q99714 1/20 0.33
LMNA P02545 3/20 0.33
OXTR P30559 1/20 0.33
GLA P06280 1/20 0.33
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
AVPR1A P37288 1/20 0.32
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22988904 0.92 MEN1 (0.39) L3MBTL1MEN1KMT2AALDH1A1KDM4E
SCHEMBL22988910 0.91 ALDH1A1 (0.41) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL22989258 0.91 MEN1 (0.38) L3MBTL1MEN1KMT2AALDH1A1KDM4E
SCHEMBL22988912 0.89 KDM4E (0.36) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL22989100 0.89 L3MBTL1 (0.36) L3MBTL1MEN1KMT2AALDH1A1KDM4E
SCHEMBL22989141 0.87 MEN1 (0.48) L3MBTL1MEN1KMT2AALDH1A1KDM4E
SCHEMBL24245525 0.87 L3MBTL1 (0.41) L3MBTL1MEN1KMT2AALDH1A1KDM4E
SCHEMBL16284573 0.85 L3MBTL1 (0.40) L3MBTL1MEN1KMT2AALDH1A1KDM4E
SCHEMBL22989080 0.85 KDM4E (0.38) L3MBTL1MEN1KMT2AALDH1A1KDM4E
SCHEMBL24245670 0.84 PDE6D (0.40) L3MBTL1MEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021029757-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME 주식회사 엘지화학 2021-02-18 WO disclosed
US-20160340361-A1 PIPERIDINE INHIBITORS OF JANUS KINASE 3 AUSPEX PHARMACEUTICALS, INC. 2016-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160340361-A1 PIPERIDINE INHIBITORS OF JANUS KINASE 3 JAK2, JAK3, PAK3 L3MBTL1 4459/4885MEN1 4552/4885KMT2A 1262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.